How high above the ground would a 10 kg object needs to be to have the same GPE as the 30 kg object in the example

Aforce of 200 n is applied to an input piston of cross-sectional area 2 sq. cm pushing it downward 2.8 cm. how far does the output piston of cross-sectional area 12 sq. cm move upward? show all work.

The particle in a two-dimensional well is a useful model for the motion of electrons around the indole ring (3), the conjugated cycle found in the side chain of tryptophan. we may regard indole as a rectangle with sides of length 280 pm and 450 pm, with 10 electrons in the conjugated p system. as in case study 9.1, we assume that in the ground state of the molecule each quantized level is occupied by two electrons. (a) calculate the energy of an electron in the highest occupied level. (b) calculate the frequency of radiation that can induce a transition between the highest occupied and lowest unoccupied levels. 9.27 electrons around the porphine ring (4), the conjugated macrocycle that forms the structural basis of the heme group and the chlorophylls. we may treat the group as a circular ring of radius 440 pm, with 20 electrons in the conjugated system moving along the perimeter of the ring. as in exercise 9.26, assume that in the ground state of the molecule quantized each level is occupied by two electrons. (a) calculate the energy and angular momentum of an electron in the highest occupied level. (b) calculate the frequency of radiation that can induce a transition between the highest occupied and lowest unoccupied levels.

Asubject in a clinical research trial experiences a serious, unanticipated adverse drug experience. how should the investigator proceed, with respect to the irb, after the discovery of the adverse event occurrence? a. do not report the adverse drug experience to the irb since it is a common adverse experience.b. report the adverse drug experience to the irb only if there are several other occurrences.c. report the adverse drug experience as part of the continuing review report.d. report the adverse drug experience in a timely manner, in keeping with the irb's policies and procedures, using the forms or the mechanism provided by the irb.